Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

NCT02338570 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Stopped on November 16th 2016, because of recruitment failure.

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Everolimus

Sponsor

Mario Negri Institute for Pharmacological Research